|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [742]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [742]
who do not qualify for DSM-IV abuse or dependence diagnoses. American Journal of Psychiatry, 156, 897–901.
Prescott, C. A., & Kendler, K. S. (1999). Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. American Journal of Psychiatry, 156, 34–40.
Project MATCH Research Group. (1997). Matching alcohol treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol, 58, 7–29.
Pulvirenti, L., Balducci, C., Piercy, M., & Koob, G. F. (1998). Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat. Journal of Pharmacology and Therapeutics, 286, 1231–1238.
Rahav, M., Rivera, J. J., Nuttbrock, L., Ng-Mak, D., Sturz, E. L., Link, B. G., et al. (1995). Characteristics and treatment of homeless, mentally ill, chemical-abusing men. Journal of Psychoactive Drugs, 27, 93–103.
Rawson, R. A., Huber, A., McCann, M. J., Shoptaw, S., Farabee, D., Reiber, C., et al. (2002). A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance for cocaine dependence. Archives of General Psychiatry, 59, 817–824.
Reich, D. L., & Silvay, G. (1989). Ketamine: An update on the first twenty-five years of clinical experience. Canadian Journal of Anaesthesiology, 36, 186–197.
Richardson, M. A., Craig, T. J., and Haughland, G. (1985). Treatment patterns of young chronic schizophrenic patients in the era of deinstitutionalization. Psychiatric Quarterly, 57, 243–249.
Ridgely, M. S., Goldman, H. H., & Willenbring, M. (1990). Barriers to the care of persons with dual diagnoses: Organizational and financing issues. Schizophrenia Bulletin, 16, 123–132.
Ridgely, M. S., & Lambert D., et al., (1999). Interagency collaboration in services for people with co-occurring mental illness and substance use disorders. Psychiatric Services, 49, 236–238.
Riggs, P. D., Mikulich, S. K., Coffman, L. M., & Crowley, T. J. (1997). Fluoxetine in drug-dependent delinquents with major depression: an open trial. Journal of Child and Adolescent Psychopharmacology, 7, 87–95.
Riggs, P. D., Mikulich, S. K., & Hall, S. (2001). Effects of pemoline on ADHD, antisocial behaviors, and substance use in adolescents with conduct disorder and substance use disorder. Paper presented at the College on Problems of Drug Dependence, 63rd Annual Scientific Meeting, Scottsdale, AZ, June 2001.
Riggs, P. D., Thompson, L. L., Mikulich, S. K., Whitmore, E. A., & Crowley, T. J. (1996). An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1018–1024.
Riggs, P. D., & Whitmore, E. A. (1999). Substance use disorders and disruptive behavior disorders. In R. L. Hendren (Ed.), Disruptive behavior disorders in children and adolescents (pp. 133–173). Washington, DC: American Psychiatric Association Press.
Roberts, D.C.S., & Ranaldi, R. (1995). Effect of dopaminergic drugs on cocaine reinforcement. Clinical Neuropharmacology, 18, S84–S95.
Robins, L., & Regier, D. (1991). Psychiatric disorders in America: The Epidemiological Catchment Area Study. New York: The Free Press.
end p.742
|
|
|
|
